SIGLEC1, also named as CD169, could function as a facilitator of the recognition and internalization of sialic acid decorated apoptotic bodies and exosomes derived from tumors, which potentially contributes to both attenuation and facilitation of anti-tumor immunity (Fraschilla and Pillai, 2017). The gene discussed is SIGLEC1; the disease is neoplasm.